Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001350910 | SCV001545338 | uncertain significance | Familial cold autoinflammatory syndrome 3 | 2020-04-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with PLCG2-related conditions. This variant is present in population databases (rs773842088, ExAC 0.001%). This sequence change falls in intron 8 of the PLCG2 gene. It does not directly change the encoded amino acid sequence of the PLCG2 protein. |
Fulgent Genetics, |
RCV002476612 | SCV002794158 | uncertain significance | Familial cold autoinflammatory syndrome 3; Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation | 2021-12-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692616 | SCV005193555 | uncertain significance | not provided | criteria provided, single submitter | not provided |